期刊文献+

不同降压药物联合应用对老年高血压患者血压变异性的影响 被引量:10

Effect of different antihypertensive drugs combined application on blood pressure variability in elderly hypertensive patients
在线阅读 下载PDF
导出
摘要 目的:探讨不同降压药联合应用对老年高血压患者血压变异性的影响。方法:收治老年原发性高血压患者120例,按照随机数字法分为A、B两组,各60例。A组给予氨氯地平联合缬沙坦治疗,B组给予缬沙坦联合氢氯噻嗪治疗。结果:服药12周后24 h SBP、24 h SBPV均较治疗前明显降低(P<0.05),但A组24 h SBPV下降更为明显(P<0.05)。与治疗前相比,服药12周后24 h DBP、24 h DBPV下降的幅度更为明显(P<0.05),A组24 h DBPV的下降幅度明显低于B组(P<0.05)。结论:老年原发性高血压患者应用氨氯地平或氢氯噻嗪与缬沙坦联合治疗,可取得显著的效果。 Objective:To investigate the effect of different antihypertensive drugs combined application on blood pressurevariability in elderly hypertensive patients.Methods:120elderly patients with primary hypertension were selected.They wererandomly divided into the A group and B group with60cases in each group.The A group was treated with amlodipine combinedwith valsartan,and B group was treated with valsartan and hydrochlorothiazide.Results:After12weeks,24h SBP,24h SBPV weresignificantly lower than those before the treatment(P<0.05),but the decrease of24h SBPV in A group was more obvious(P<0.05).Compared with before the treatment,the decrease of24h DBP and24h DBPV was more obvious(P<0.05)after12weeks,and thedecrease of24h DBPV in A group was lower than that in group B(P<0.05).Conclusion:For elderly patients with primaryhypertension,amlodipine or hydrochlorothiazide combined with valsartan can achieve significant results.
作者 王萌 Wang Meng(Doudian Community Health Service Center of Fangshan District,Beijing City 102433)
出处 《中国社区医师》 2017年第27期16-17,共2页 Chinese Community Doctors
关键词 氢氯噻嗪 缬沙坦 氨氯地平 高血压 血压变异性 Hydrochlorothiazide Stan Amlodipine Hypertension Blood pressure variability
  • 相关文献

参考文献8

二级参考文献65

  • 1洪德军.辛伐他汀治疗血脂异常高危患者60例效果观察[J].南通大学学报(医学版),2009,29(6):520-521. 被引量:10
  • 2张维忠.血压变异和晨峰的概念及其临床意义[J].中华心血管病杂志,2006,34(3):287-288. 被引量:300
  • 3滕志涛,唐蓉,陈焕章,郭丽蓉,马欲晓,黄蕊茵,吴荣,李卫华.普伐他汀对高血压病人降压平滑性指数的影响[J].高血压杂志,2006,14(7):572-573. 被引量:1
  • 4Parati G,Pomidossi G,Albini F,et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organdamage in hypertension[ J]. J Hypertens,1987,5( 1 ):93-98.
  • 5Rothwell PM, Howard SC, Dolan E, et al. Prognostic signifi- cance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension [ J ]. Lancet, 2010,375 (9718) :895 -905.
  • 6Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cho- lesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension [ J ]. J Am Coil CardioI,2002,39(6) : 1 020 - 1 025.
  • 7Pelat M, Dessy C, Massion P, et al. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo [ J ]. Circulation,2003,107 (19) :2 480 - 2 486.
  • 8Blacher J, Protogerou AD, Safar ME. Large artery stiffness and antihypertensive agents [ J ]. Curr Pharm Des, 2005,11 (25) :3 317 -3 326.
  • 9Danaolu Z, Ktilttirsay H, Kayikcio,lu M, et al. Effect of sta- tin therapy added to ACE-inhibitors on blood pressure con- trol and endothelial functions in normolipidemie hyperten- sive patients [ J ]. Anadolu Kardiyol Derg, 2003, 3 ( 4 ) : 331 - 337.
  • 10Parati G, Ochoa JE, Lombardi C, et al. Assessment and manage- ment of blood-pressure variability [J]. Nat Rev Cardiol, 2013,10(3): 143-155.

共引文献196

同被引文献53

引证文献10

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部